PFO closure with the Premere PFO closure device: Acute results and follow-up of 263 patients

EuroIntervention

Volumn 8, Issue 3, 2012, Pages 345-351

  Stanczak, Lukasz J ^a   Bertog, Stefan C ^a   Wunderlich, Nina ^a   Franke, Jennifer ^a   Sievert, Horst ^a  

^a CARDIOVASCULAR CENTER FRANKFURT   (Germany)

Author keywords

Congenital heart disease; Patent foramen ovale; Residual shunt; Transcatheter closure

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIAC EQUIPMENT; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLOSURE DEVICE; ECHOCARDIOGRAPH; FALSE ANEURYSM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; PATENT FORAMEN OVALE; PATIENT SAFETY; PERICARDIAL EFFUSION; SURGICAL APPROACH; TREATMENT OUTCOME; TRICUSPID ANNULOPLASTY; TRICUSPID VALVE REGURGITATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIAC SURGICAL PROCEDURES; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FOLLOW-UP STUDIES; FORAMEN OVALE, PATENT; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SEPTAL OCCLUDER DEVICE; STROKE;

EID: 84872067947     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV8I3A53     Document Type: Article

References (26)

1. Sievert H, Ruygrok P, Salkeld M, Baumgartner H, Meier B, Windecker S, Juliard J-M, Aubry P, Tiefenbacher C, Krumsdorf U, Vermeersch P, Ewert P, Piéchaud JF. Transcatheter closure of patent foramen ovale with radiofrequency: acute and intermediate term results in 144 patients. Catheter Cardiovasc Interv. 2009;73: 368-73.
2. Bridges ND, Hellenbrand W, Latson L, Filiano J, Newburger JW, Lock JE. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation. 1992;86: 1902-8.
3. Sievert H, Horvath K, Zadan E, Krumsdorf U, Fach A, Merle H, Scherer D, Schräder R, Spies H, Nowak B, Lissmann-Jensen H. Patent foramen ovale closure in patients with transient ischemia attack/stroke. J Interv Cardiol. 2001;14:261-6.
4. Billinger K, Ostermayer SH, Carminati M, Degiovanni JV, Ewert P, Hess J, Maymone-Martins FA, Qureshi SA, Salmon AP, Schneider M, Wilson N, Sievert H. HELEX Septal Occluder for transcatheter closure of patent foramen ovale: multicentre experience. EuroIntervention. 2006;1:465-71.
5. Büscheck F, Sievert H, Kleber F, Tiefenbacher C, Krumsdorf U, Windecker S, Uhlemann F, Wahr DW. Patent foramen ovale using the Premere device: the results of the CLOSEUP trial. J Interv Cardiol. 2006;19:328-33.
6. Donti A, Giardini A, Salomone L, Formigari R, Picchio FM. Transcatheter patent foramen ovale closure using the Premere PFO occlusion system. Catheter Cardiovasc Interv. 2006;68:736-40.
7. Rigatelli G, Cardaioli P, Braggion G, Giordan M, Fabio D, Aggio S, Roncon L, Chinaglia M. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia. Catheter Cardiovasc Interv. 2007;70:429-33.
8. Reyes RM, Galeote G, Moreno R, Calvo L, Villate A, Vanegas M, Sanchez-Recalde A, Jiménez-Valero S, Lopez T, Moreno M, Gonzaga A, Moreno-Gomez I, Lopez-Sendón J-L. Percutaneous PFO closure using the Premere device occluder: initial experience. Rev Port Cardiol. 2009;28:1225-30.
9. Rigatelli G, Cardaioli P, Dell'avvocata F, Giordan M, Chinaglia M. Premere occlusion system for transcatheter patent foramen ovale closure: mid-term results of a single-center registry. Catheter Cardiovasc Interv. 2011;77:564-9.
10. Kleber FX, Winkelmann A, Stretz A, Sonntag SM, Bruch L, Rademacher G, Sparenberg P, Schmehl I. Occlusion of PFO with a dedicated adjustable device: influence on one year outcome. EuroIntervention. 2010;6:367-70.
11. Thaman R, Faganello G, Gimeno JR, Szantho GV, Nelson M, Curtis S, Martin RP, Turner MS. Efficacy of percutaneous closure of patent foramen ovale: comparison among three commonly used occluders. Heart. 2011;97:394-9.
12. Bissessor N, Wong AW, Hourigan LA, Jayasinghe RS, Scalia GS, Burstow DJ, Griffiths LR, Savage M, Walters DL. Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices. Cardiovasc Revasc Med. 12:164-9.
13. Shanewise JS, Cheung AT, Aronson S, Stewart WJ, Weiss RL, Mark JB, Savage RM, Sears-Rogan P, Mathew JP, Quiñones MA, Cahalan MK, Savino JS. ASE/SCA guidelines for performing a comprehensive intraoperative multiplane transesophageal echocardiography examination: recommendations of the American Society of Echocardiography Council for Intraoperative Echocardiography and the Society of Cardiovascular Anesthesiologists Task Force for Certification in Perioperative Transesophageal Echocardiography. Anesth Analg. 1999;89:870-84.
14. Saremi F, Channual S, Raney A, Gurudevan SV, Narula J, Fowler S, Abolhoda A, Milliken JC. Imaging of patent foramen ovale with 64-section multidetector CT. Radiology. 2008;249:483-92.
15. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med. 2003;139:753-60.
16. Wahl A, Kunz M, Moschovitis A, Nageh T, Schwerzmann M, Seiler C, Mattle HP, Windecker S, Meier B. Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism. Heart. 2008;94:336-41.
17. Staubach S, Steinberg DH, Zimmermann W, Wawra N, Wilson N, Wunderlich N, Sievert H. New onset atrial fibrillation after patent foramen ovale closure. Catheter Cardiovasc Interv. 2009;74:889-95.
18. Spies C, Khandelwal A, Timmermanns I, Schräder R. Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults. Am J Cardiol. 2008;102:902-6.
19. Bonvini RF, Sztajzel R, Dorsaz P-A, Righini M, Bonvin C, Alibegovic J, Sigwart U, Camenzind E, Verin V, Sztajzel J. Incidence of atrial fibrillation after percutaneous closure of patent foramen ovale and small atrial septal defects in patients presenting with cryptogenic stroke. Int J Stroke. 2010;5:4-9.
20. Taaffe M, Fischer E, Baranowski A, Majunke N, Heinisch C, Leetz M, Hein R, Bayard Y, Büscheck F, Reschke M, Hoffmann I, Wunderlich N, Wilson N, Sievert H. Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder). Am J Cardiol. 2008;101:1353-8.
21. Jarral OA, Saso S, Vecht JA, Harling L, Rao C, Ahmed K, Gatzoulis MA, Malik IS, Athanasiou T. Does patent foramen ovale closure have an anti-arrhythmic effect? A meta-analysis. Int J Cardiol. 2011;153:4-9.
22. Staubach S, Bertog S, Wunderlich N, Sievert H. Late complications of transcatheter closure of patent foramen ovale: new technology and new outcomes. Future cardiol. 2009;5:503-10.
23. Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, Sievert H. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol. 2004;43:302-9.
24. Sztajzel R, Genoud D, Roth S, Mermillod B, Le Floch-Rohr J. Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis. 2002;13:102-6.
25. Trabattoni D, Fabbiocchi F, Montorsi P, Galli S, Teruzzi G, Grancini L, Gatto P, Bartorelli AL. Sustained long-term benefit of patent foramen ovale closure on migraine. Catheter Cardiovasc Interv. 2011;77:570-4.
26. Shafi NA, McKay RG, Kiernan FJ, Silverman IE, Ahlquist M, Silverman DI. Determinants and clinical significance of persistent residual shunting in patients with percutaneous patent foramen ovale closure devices. Int J Cardiol. 2009;137:314-6.